KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Change in Accured Expenses (2016 - 2025)

Novavax has reported Change in Accured Expenses over the past 16 years, most recently at -$21.5 million for Q4 2025.

  • Quarterly results put Change in Accured Expenses at -$21.5 million for Q4 2025, up 49.27% from a year ago — trailing twelve months through Dec 2025 was -$322.6 million (up 16.35% YoY), and the annual figure for FY2025 was -$322.6 million, up 16.35%.
  • Change in Accured Expenses for Q4 2025 was -$21.5 million at Novavax, up from -$26.5 million in the prior quarter.
  • Over the last five years, Change in Accured Expenses for NVAX hit a ceiling of $823.0 million in Q4 2022 and a floor of -$272.5 million in Q1 2024.
  • Median Change in Accured Expenses over the past 5 years was -$28.0 million (2023), compared with a mean of $21.3 million.
  • Biggest five-year swings in Change in Accured Expenses: soared 731.07% in 2021 and later crashed 316.6% in 2022.
  • Novavax's Change in Accured Expenses stood at $419.6 million in 2021, then surged by 96.13% to $823.0 million in 2022, then tumbled by 103.59% to -$29.5 million in 2023, then crashed by 43.74% to -$42.5 million in 2024, then soared by 49.27% to -$21.5 million in 2025.
  • The last three reported values for Change in Accured Expenses were -$21.5 million (Q4 2025), -$26.5 million (Q3 2025), and -$62.6 million (Q2 2025) per Business Quant data.